Compagnie Lombard Odier S Cm A Neogenomics Inc Transaction History
Compagnie Lombard Odier S Cm A
- $7.73 Billion
- Q1 2025
Shares
2 transactions
Others Institutions Holding NEO
# of Institutions
275Shares Held
120MCall Options Held
751KPut Options Held
107K-
Black Rock Inc. New York, NY19.7MShares$154 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.2MShares$112 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.53MShares$51.2 Million0.07% of portfolio
-
Janus Henderson Group PLC London, X06.17MShares$48.3 Million0.05% of portfolio
-
State Street Corp Boston, MA5.2MShares$40.8 Million0.0% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $986M
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...